baber/WOPTO huggingface dataset:
Patent NZ-542673-A (NZ)
Title: Apparatus for and method of forming concrete and transferring loads between concrete slabs
Inventor: MCDONALD STEPHEN F
Filed: 2005-09-28
Abstract: A plate or dowel for transferring a load between adjacent concrete slabs is disclosed. The plate or dowel (1110) has edge banding (1105) disposed on a surface of a first portion and an elastomer coating (1115) disposed on the first portion and the edge banding. When the plate or dowel is placed in the joint between slabs the first concrete slab contacts only the elastomer coating and the second slab only adheres to a second portion of the plate or dowel. The first concrete slab may move relative to the plate or dowel.
Patent NZ-549528-A (NZ)
Title: Method of making skin equivalents having improved barrier function
Inventor: COMER ALLEN
IPC: C12Q1/68
Filed: 2002-03-01
Abstract: Disclosed is a method of making skin equivalents having improved barrier function comprising: a) providing NIKS cells and a culture media comprising ascorbic acid and linoleic acid; b) culturing said NIKS cells under conditions such that a skin equivalent having improved barrier function is formed, wherein said skin equivalent has surface electrical capacitance of 40 to 240pF. (62) Divided Out of 528166
Patent NZ-553296-A (NZ)
Title: Anti-collision warning system for marine vehicles and anti-collision analysis method
Inventor: WAQUET PHILIPE
IPC: G01S17/93
Filed: 2005-09-29
Abstract: An anti-collision warning method in an anticollision warning system for marine vehicles is disclosed. The system comprises at least one optical sensor covering at least partially the horizon of the marine vehicle. The method comprises steps of: acquiring from the optical sensor images including a portion of the horizon of the marine vehicle, searching in real time in each image acquired for groups of adjacent pixels according to the light intensity of each pixel of the image, assessing persistence of each group of pixels in successive images acquired, determining groups constituting objects visible on the surface of the sea, according to their persistence, determining position and dimension information of at least one of the visible objects, periodically calculating the evolution of the position and dimension information of the visible object, and assessing a risk of the marine vehicle colliding with the visible object according to the evolution of the position and dimension information of the visible object, a visible object being considered dangerous if there is a risk of the marine vehicle colliding with the visible object.
Patent NZ-553576-A (NZ)
Title: Wind turbine comprising a generator cooling system
Inventor: WOBBEN ALOYS
Filed: 2005-09-23
Abstract: The disclosure relates to a wind turbine comprising a tower, a nacelle that is rotatably mounted on said tower, a generator that is located in the nacelle and comprises a rotor and a stator and at least one fan in the vicinity of the nacelle. To reduce the entry of moisture, sand and other foreign bodies into the nacelle and the noise of the fan that is externally audible, the fan is located inside the nacelle and sucks air from the exterior through an air gap that is open at the bottom and lies between the tower and the nacelle.
Patent NZ-553722-A (NZ)
Title: Dihydropteridinones for the treatment of cancer diseases
Inventor: MUNZERT GERD
IPC: A61K31/519
Filed: 2005-08-09
Abstract: Disclosed is the use of the dihydropteridinone compounds (46) and (110) in the preparation of a pharmaceutical preparation or a medicament for the treatment of particular cancers, particular autoimmune disorders and fungal diseases. The particular cancers are carcinomas, sarcomas, melanomas, myeloma, hematologic neoplasias, lymphomas, childhood cancers and leukaemia. The particular autoimmune disorders are selected from Amyloidosis, Systemic lupus erythematosus, Rheumatoid Arthritis, Crohn's disease, multiple sclerosis, systemic sclerosis (scleroderma), mixes connective tissue disease, Sjogren's syndrome, ankylosing spondylitis, autoimmune vasculitis, Behcet's syndrome, psoriasis, autoimmune arthritis, sarcoidosis and diabetes mellitus. Some fungal diseases particularly disclosed are candidiasis, cryptococcosis, aspergillosis, mucormycosis, tinea, dermatophytosis, histoplasmosis, blastomycosis, coccidiosis and pneumocystis.
Patent NZ-554393-A (NZ)
Title: Ablation catheter with limited span electrodes
Inventor: ANDERSON NEILL LAWRENCE
IPC: A61M25/00
Filed: 2003-05-09
Abstract: An ablation catheter includes an elongate tubular carrier 12 defining a lumen 24 and an outer periphery and conductors 30 extending along the outer surface of the tubular member with the conductors being covered with a coating 31 of an insulating material that forms the outer periphery. Ablating electrodes 16 are carried on the outer periphery and are arranged only partially about the periphery of the carrier.
Patent NZ-555072-A (NZ)
Title: Copper containing materials for treating wounds, burns and other skin conditions
Inventor: GABBAY JEFFREY
IPC: A61K33/34
Filed: 2005-11-07
Abstract: Disclosed is the use of copper (I) oxide and/or copper (II) oxide in the manufacture of a medicament for the treatment of sores, abrasions, ulcerations, lesions, cutaneous opening and burns, wherein the medicament is embedded in a polymeric fibre, filament, sheet or sheath and wherein Cu+ ions, Cu++ ions or combinations are released from the medicament upon contact with a fluid. Further disclosed is the use poorly soluble copper compounds for the manufacture of a composition for the treatment of sores, abrasions, ulcerations, lesions, cutaneous opening and burns, wherein the composition can be embedded in a fiber or a polymeric film.
Patent NZ-555681-A (NZ)
Title: Imidazo[1, 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
Inventor: CURRIE KEVIN S
IPC: C07D487/04
Filed: 2005-11-10
Abstract: Disclosed is at least one chemical entity chosen from compounds of Formula 1 and pharmaceutically acceptable salts, solvates, crystal forms, chelates, prodrugs, and mixtures thereof, wherein R5 is optionally substituted aryl and the rest of the substituents are disclosed within the specification. Also disclosed is the use of the above compound for the preparation of a medicament for treating a patient having a disease responsive to inhibition of Btk activity.
Patent NZ-556084-A (NZ)
Title: A milking device
Inventor: HAGGLUND CHRISTOFFER
IPC: A01J/
Filed: 2006-01-10
Abstract: The disclosure refers to a milking device for milking an animal during a milking operation. A milking member (5) comprises at least one teatcup to be attached to a teat of the animal. A long milk conduit (10) extends from the milking member for being connected to a milking machine. A support device comprises a mounting device mounted to a stationary structure, and a support arm (17a) in parallel to an arm axis and connected to the mounting device. The milking member is freely movable along the support arm. The milking member is attached to the support arm and displaceable on the support arm. The support arm comprises a primary arm element (17a') connected to the mounting device and a secondary arm element (17a") holding the milking member. The primary arm element is telescopically movable into the secondary arm element, which is displaceable on the primary arm element.
Patent NZ-564203-A (NZ)
Title: On-demand reverse link pilot transmission
Inventor: SUTIVONG ARAK
IPC: H04W72/12
Filed: 2005-07-19
Abstract: An apparatus in a communication system includes means for selecting at least one terminal for pilot transmission on a reverse link. The terminals are candidates for data transmission on a forward link. The apparatus also includes means for processing pilot transmission from each of the terminals; means for deriving a channel estimate for each of the terminals based on the pilot transmission from the terminal; and means for transmitting data on the forward link to each terminal scheduled for data transmission using the channel estimate for the terminal. A terminal for use with the above described apparatus includes a controller operative to receive a request for pilot transmission on a reverse link and to determine a time-frequency allocation for the pilot transmission; and a processor operative to generate a pilot for transmission on the reverse link on the time-frequency allocation. The pilot transmission on the reverse link is used for scheduling the terminal for data transmission on a forward link, for spatial processing of data transmission to the terminal, or for both scheduling and spatial processing.
Patent NZ-566473-A (NZ)
Title: 3-(2-Dimethylaminomethyl cyclohexyl) phenol retard formulation
Inventor: JUNG TOBIAS
IPC: A61K9/22
Filed: 2006-09-15
Abstract: Disclosed is a dosage form adapted for controlled release of an active ingredient 3-(2-dimethylaminomethylcyclohexyl)phenol or a pharmaceutically acceptable salt thereof, which achieves in vivo the peak plasma level of the active ingredient after 2 to 10 h wherein the pharmaceutically acceptable salt is selected from the group consisting of hydrochlorides, hydrobromides, sulfates, phosphates, hydrogenphosphates, dihydrogenphosphates, formates, acetates, propionates, fumarates, glutarates, pyruvates, malates, tartrates, benzoates, citrates, ascorbates, and maleates. Also disclosed is the use of said dosage form for treating pain or vomiting.
Patent NZ-577716-A (NZ)
Title: Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline
Inventor: VORHOEST PATRICK ROBERT
IPC: A61K31/415
Filed: 2007-12-03
Abstract: Disclosed is the crystalline succinate salt of the compound 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline. Further disclosed is a pharmaceutical composition comprising the succinate salt as defined above , and a pharmaceutically acceptable carrier for treating psychotic disorders, delusional disorders and drug induced psychosis; anxiety disorders, movement disorders, mood disorders, neurodegenerative disorders and drug addiction.
Patent NZ-578836-A (NZ)
Title: Application of an electric signal comprising a non-sinusoidal waveform having a pulse repetition rate in the range of 20Hz-100Hz to headphones for tinnitus treatment
Inventor: WINKLER PETER ANTHONY
IPC: A61N1/00
Filed: 2007-12-19
Abstract: A method of applying an electric signal to a headphone or like acoustic transducer is disclosed. The electric signal comprises a non-sinusoidal pulsating electric waveform selected from the group consisting of square waves, triangle waves, and sawtooth waves each having a pulse repetition rate in the range of approximately 20Hz to less than 100Hz. The waveform comprises a sequence comprising a plurality of at least two of the square waves, triangle waves, or sawtooth waves each of predetermined duration.
Patent NZ-579615-A (NZ)
Title: Segmented savonius rotor with blades fixed to sleeve by struts
Inventor: MORGAN KEN
IPC: F03D3/02
Filed: 2008-02-13
Abstract: A segmented rotor for a vertical rotor wind turbine includes a plurality of rotor segments that are installed onto a shaft that is connected to the electrical generator of the turbine. Each rotor blade segment (44) includes a hollow sleeve (50) for installation over the shaft, at least two rotor blades (46, 48) that are positioned in a fixed relationship with respect to one another, and at least two fixed struts (54) for connecting each of the rotor blades to the sleeve. A first of the two struts is attached perpendicularly to an upper, inner surface of a first of the blades and to an upper portion of the sleeve, and a second of the two struts is attached perpendicularly to a lower, inner surface of said first blade and to a lower portion of the sleeve.
Patent NZ-584104-A (NZ)
Title: Coating compositions exhibiting corrosion resistance properties and methods of coil coating
Inventor: SPEHAR JEAN MARC
IPC: C09D5/08
Filed: 2007-09-28
Abstract: Disclosed are coating compositions exhibiting corrosion resistance properties. These compositions include a non-chrome corrosion resisting filler and a radiation curable film-forming binder comprising an unsaturated monomer comprising a nitrogen-containing cyclic structure and one ethylenically unsaturated double bond. Also disclosed are methods for roll coating a metal coil.
Patent NZ-584585-A (NZ)
Title: Injectable formulations comprising a macrocylclic lactone, benzyl alcohol and a biodegradable polyester
Inventor: CORGOZINHO CAROLINA NUNES COSTA
IPC: A61K31/365
Filed: 2008-10-24
Abstract: Disclosed is a liquid long acting injectable formulation for combatting ectoparasites and endoparasites in an animal, wherein said formulation comprises: a) a therapeutically effective amount of at least one macrocyclic lactone (such as abamectin, doramectin, emamectin, eprinomectin, ivermectin, lepimectin, selamectin, milbemectin, milbemycin D, milbemycin oxime, moxidectin and mixtures thereof); b) benzyl alcohol or a mixture thereof with benzyl benzoate and/or glycerol formal as a solvent; and c) at least one biologically acceptable and biodegradable polyester polymer selected from the group consisting of polylactides, polycaprolactones, polyglycolides and copolymers thereof.
Patent NZ-589227-A (NZ)
Title: Wind turbine with direct drive generator with flexible in the axial direction end plates maintaining an air gap between the stator and rotor supported using a four point bearing
Inventor: STIESDAL HENRIK
IPC: F03D11/00
Filed: 2009-07-02
Abstract: Disclosed is a wind turbine with a simplified design and an improved load capacity. The wind turbine comprises a direct drive generator comprising an inner stator arrangement and an outer rotor arrangement and a stationary shaft having a centre axis. The stator arrangement is arranged on the outside of the stationary shaft, the rotor arrangement is substantially arranged around the stator arrangement. The rotor arrangement on the front side at least indirectly supported or arranged on the stationary shaft by a main bearing and on the rear side at least indirectly supported or arranged on the stationary shaft by a support bearing. The main bearing and/or the support bearing is a four-point bearing. The rotor arrangement comprises a ring-shaped front endplate made of steel or fibreglass with a thickness of 15 - 50 mm which is at least indirectly supported or arranged on the stationary shaft by the main bearing, and the front endplate is at least partially flexible in the directions of the centre axis of the stationary shaft. A ring-shaped rear endplate made of steel or fibreglass is at least indirectly supported or arranged on the stationary shaft by the support bearing.
Patent NZ-589318-A (NZ)
Title: Pyrrolopyridines as kinase inhibitors
Inventor: LE HUEROU YVAN
IPC: A61K31/437
Filed: 2009-05-13
Abstract: Disclosed is a aminopiperidin-1H-pyrrolo[2,3-b]pyridine-3-yl amide selected from Formula 1 and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein: A, R1, R2, R3 and R4, R5, R6, R6a, R7 is defined the specification and p is 0, 1, 2 or 3. Also disclosed is the use of said amide for the treatment of cancer and process to prepare said compound.
Patent NZ-590115-A (NZ)
Title: Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1
Inventor: BURIONI ROBERTO
IPC: G01N33/569
Filed: 2009-05-27
Abstract: A human monoclonal antibody directed against the haemagglutinin of the influenza A virus. The antibody has neutralising activity against a plurality of H1-subtype influenza A viruses comprising at least one human-derived isolate and one animal-derived isolate. The antibody can recognise A/Puerto Rico/8/34, A/Wilson-Smith/33 and A/Malaya/302/54 and A/California/04/2009.
Patent NZ-600898-A (NZ)
Title: Waste water treatment equipment
Inventor: LI JINMIN
IPC: B01D21/01
Filed: 2010-12-01
Abstract: 600898 A waste water treatment equipment comprises a first stage equipment for treating waste water feed to obtain a first effluent and a second stage equipment for treating the first effluent to obtain a second effluent. The second stage equipment comprises a mixer (VI) for mixing the first effluent and a flocculation agent to obtain the first effluent containing the flocculation agent and flocculation-clarification equipment (VII). The flocculation-clarification equipment comprises a first flocculation reaction chamber, into which the first effluent containing the flocculation agent is entered and subjected to flocculation reaction to form a mixture of water and sludge; a first separation chamber, into which the mixture of water and sludge from the first flocculation reaction chamber is entered and separated to obtain a first part of the second effluent and a first sludge; and a second separation chamber, into which a first part of the first sludge is entered and separated to obtain a second part of the second effluent and a second sludge. The flocculation clarification device further comprises: one or more first dreg discharging channels fluidly communicating the first separation chamber and the second separation chamber to allow the entrance of a first part of the first dreg into the second separation chamber, and one or more first dreg returning channels fluidly communicating the first separation chamber and the flocculation reaction chamber to allow the entrance of a second part of the first dreg into the flocculation reaction chamber. In the first separation chamber, an inlet of the first dreg discharging channels is at a position higher than an inlet of the first dreg returning channels.
Patent NZ-601164-A (NZ)
Title: Method for Manufacturing a Molten Metal
Inventor: TETSUMOTO MASAHIKO
IPC: C21B13/10
Filed: 2012-07-09
Abstract: 601164 A method for manufacturing molten metal in a stationary non-tilting electric furnace including electric heating means 5, where an exhaust gas duct and at least one raw material charging chute 4 are connected to a furnace top of the furnace. The raw material charging chute 4 is provided in one end of the furnace in the width direction, and a secondary combustion burner 6 is provided in the furnace top. The method comprises forming a raw material layer 12 by charging a particular amount of a carbonaceous material and/or a metal agglomerate raw material into the furnace from the raw material charging chute 4. The raw material layer 12 has a sloping surface extending downward from the one end of the furnace in the width direction toward an electric heating region heated with the electric heating means 5. Then a metal agglomerate raw material layer 12a is formed on the sloping surface of the raw material layer 12 by continuously or intermittently charging the metal agglomerate raw material into the furnace from the raw material charging chute 4. The metal agglomerate raw material near a lower end portion of the metal agglomerate raw material layer 12a is melted by the electric heating means 5 forming a molten metal layer and a molten slag layer, while allowing the metal agglomerate raw material layer to descend along the sloping surface of the raw material layer, and concurrently thermally reducing the metal agglomerate raw material layer by radiant heat from secondary combustion by blowing oxygen containing gas into a space within the furnace, above the metal agglomerate raw material layer from the secondary combustion burner 6 to burn CO-containing gas generated from the metal agglomerate raw material layer.
Patent NZ-601772-A (NZ)
Title: Amino Acid Prodrugs
Inventor: CHANDRAN V
IPC: A61K/
Filed: 2004-07-29
Abstract: Provided is a drug-conjugate product obtained by reacting the drug with an alpha-L- amino acid containing one or more hydroxyl groups on the side chains thereof under conditions effective to form a compound having a covalent bond between the drug and the alpha-L-amino acid, wherein the drug is selected from a list of specified drugs (including ibuprofen and aspirin), ), and characterized in that said drug-conjugate product provides for an enhanced therapeutic quality of the drug, the enhanced therapeutic quality being selected from the group consisting of: (a) improved taste or smell, (b) desired octanol/water partition coefficient, (c) improved stability, (d) enhanced penetration of blood-brain barrier, (e) elimination of first pass effect in the liver, (f) reduction of intero-hepatic recirculation, (g) painless injection with parental formulation, (h) improved bioavailability, (i) improved changes in the rate of absorption, (j) reduced side effects, (k) dose proportionality, (l) selective hydrolysis at site of action, (m) controlled release properties, (n) targeted drug delivery, (o) reduction in toxicity, (p) reduced dose, (q) alteration of metabolic pathway to deliver more drug at site of action, (r) increased solubility in aqueous solution and (s) enhanced efficacy, with the proviso that the amino acid moiety is not L-Proline, and L-Hydroxyproline.
Patent NZ-601924-A (NZ)
Title: 4-phenyl pyridine analogues as protein kinase inhibitors
Inventor: NIESTROJ ANDRE J
IPC: C07D417/12
Filed: 2011-03-10
Abstract: Disclosed herein are pyridine-aryl compounds of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inhibitors of protein kinases, in particular members of the cyclin-dependent kinase family and/or the glycogen synthase kinase 3 family and as such are useful in the treatment and/or prevention of any type of pain, inflammatory disorders, cancer, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, metabolic disorders, renal diseases, neurologic and neuropsychiatric diseases and neurodegenerative diseases. Examples of particularly preferred compounds include N-(4-(4-Fluoro-2-methoxyphenyl)pyridin-2-yl)cyclohexanecarboxamide; 2-Cyclohexyl-N-(4-(4-fluoro-2-methoxyphenyl)pyridin-2-yI)acetamide; N-(4-(4-Fluoro-2-methoxyphenyl)pyridin-2-yl)piperidine-4-carboxamide; 2-(4-(4-Methylpiperazin-1-yl)benzyl)-N-(4-(4-fluoro-2-methoxyphenyl)-pyridin-2-yl)propanamide; (1R,3S)-3-Acetamido-N-(4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl)cyclopentanecarboxamide; cis-N-(4-(4-FIuoro-2-methoxyphenyl)pyridin-2-yl)-4-(thiazol-2-ylamino)-yclohexanecarboxamide.
Patent NZ-623034-A (NZ)
Title: Dispenser for particulate matter and method of use
Inventor: ANDREW TRAFFORD KING
IPC: B65D83/06
Filed: 2013-05-22
Abstract: Disclosed are a dispenser (1) and a method for dispensing particulate matter, such as ground coffee beans. The disclosure notes that coffee beans contain natural oils which cause ground coffee to have a sticky characteristic when the coffee beans are heavily roasted or finely ground. The sticky characteristic results in difficulties such as tamping of a basket of a Moka pot when brewing coffee. The dispenser (1) includes a hopper (2); a coupling; an aperture and a stirrer (12). The coupling allows attachment of the hopper (1), either directly or indirectly, to a receptacle. The aperture moves between an open position and a closed position to allow or prevent the flow of the particulate matter between the hopper (1) and the receptacle. The stirrer (12) includes a plurality of spokes (16) and is housed in the hopper (1). The stirrer (12) moves in a substantially vertical and rotational manner within the hopper (1).
Patent NZ-700669-A (NZ)
Title: A device to enhance the traction of a tracked vehicle
Inventor: BURLING JOHN MENZIES
IPC: B62D55/28
Filed: 2011-02-08
Abstract: A grouser for use with a continuous track of a tracked vehicle to enhance the traction of the vehicle is disclosed. The device has an elongate body (5) having a plurality of teeth (39) and a releasable bracket (7) for releasably securing the elongate body (5) to the continuous track. A kit of parts is also described.